CLAIRE CURRAN: Open Payments
NPI 1104529791 · OAK BROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,102 in 160 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $582 · 2025 $3,102
Food & beverage: $3,088Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $532 |
| Novo Nordisk Inc | 23 | $473 |
| Lilly USA, LLC | 15 | $305 |
| Currax Pharmaceuticals LLC | 25 | $244 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $176 |
| Madrigal Pharmaceuticals | 3 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $168 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $164 |
| Boston Scientific Corporation | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 1 | $108 |
Products named: Wegovy, VRAYLAR, JARDIANCE, ONZETRA XSAIL, Kerendia, REZDIFFRA, CREON, ISTURISA.
Industry payments across IL — which companies pay providers there.
